|
US4200750A
(en)
|
1977-01-07 |
1980-04-29 |
Westwood Pharmaceuticals Inc. |
4-Substituted imidazo [1,2-a]quinoxalines
|
|
US6069143A
(en)
|
1994-12-20 |
2000-05-30 |
Smithkline Beecham Corporation |
Fibrinogen receptor antagonists
|
|
ATE448193T1
(de)
|
2002-01-18 |
2009-11-15 |
Merck & Co Inc |
ßN-(BENZYL)AMINOALKYL CARBOXYLATE, PHOSPHINATE, PHOSPHONATE UND TETRAZOLE ALS EDG REZEPTORAGONISTENß
|
|
US7479504B2
(en)
|
2002-01-18 |
2009-01-20 |
Merck & Co., Inc. |
Edg receptor agonists
|
|
US20050070506A1
(en)
|
2002-01-18 |
2005-03-31 |
Doherty George A. |
Selective s1p1/edg1 receptor agonists
|
|
US7309721B2
(en)
|
2002-03-01 |
2007-12-18 |
Merck + Co., Inc. |
Aminoalkylphosphonates and related compounds as Edg receptor agonists
|
|
JP2005533058A
(ja)
|
2002-06-17 |
2005-11-04 |
メルク エンド カムパニー インコーポレーテッド |
Ｅｄｇ受容体アゴニストとしての１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）アゼチジン−３−カルボキシラートおよび１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）ピロリジン−３−カルボキシラート
|
|
US20060252741A1
(en)
*
|
2003-05-15 |
2006-11-09 |
Colandrea Vincent J |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
|
|
BRPI0410439A
(pt)
|
2003-05-19 |
2006-06-06 |
Irm Llc |
compostos e composições imunossupressoras
|
|
CN1859908A
(zh)
*
|
2003-10-01 |
2006-11-08 |
默克公司 |
作为s1p受体激动剂的3,5－芳基、杂芳基或环烷基取代的－1,2,4－噁二唑类化合物
|
|
US7605171B2
(en)
|
2003-12-17 |
2009-10-20 |
Merck & Co., Inc. |
(3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists
|
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
|
AU2005299851B2
(en)
|
2004-10-22 |
2011-03-17 |
Merck Sharp & Dohme Corp. |
2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as S1P receptor agonists
|
|
BRPI0609668A2
(pt)
|
2005-03-23 |
2011-10-18 |
Actelion Pharmaceuticals Ltd |
composto, composição farmacêutica, e, uso de um composto
|
|
CN101203512A
(zh)
|
2005-04-22 |
2008-06-18 |
第一三共株式会社 |
杂环化合物
|
|
BRPI0612028A2
(pt)
|
2005-06-08 |
2010-10-13 |
Novartis Ag |
oxadiazóis ou isodiazóis policìclicos e uso dos mesmos como ligantes de receptor s1p
|
|
WO2007024922A1
(en)
|
2005-08-23 |
2007-03-01 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
WO2007088450A2
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
|
JP2009530389A
(ja)
|
2006-03-21 |
2009-08-27 |
エピックス デラウェア， インコーポレイテッド |
Ｓ１ｐ受容体調節化合物及びその使用
|
|
MX2008012738A
(es)
|
2006-04-03 |
2009-02-06 |
Astellas Pharma Inc |
Heterocompuesto.
|
|
JP2009269819A
(ja)
|
2006-08-25 |
2009-11-19 |
Asahi Kasei Pharma Kk |
アミン化合物
|
|
ES2400163T3
(es)
|
2006-09-08 |
2013-04-08 |
Actelion Pharmaceuticals Ltd. |
Derivados de piridil-3-ilo como agentes de inmunomodulación
|
|
GB0625648D0
(en)
|
2006-12-21 |
2007-01-31 |
Glaxo Group Ltd |
Compounds
|
|
PT2125797E
(pt)
|
2007-03-16 |
2014-03-11 |
Actelion Pharmaceuticals Ltd |
Derivados aminopiridina como agonistas do receptor s1p1/edg1
|
|
ES2622423T3
(es)
|
2007-10-04 |
2017-07-06 |
Merck Serono S.A. |
Derivados de oxadiazol
|
|
RU2010121969A
(ru)
|
2007-11-01 |
2011-12-10 |
Актелион Фармасьютиклз Лтд (Ch) |
Новые производные пиримидина
|
|
GB0725105D0
(en)
|
2007-12-21 |
2008-01-30 |
Glaxo Group Ltd |
Compounds
|
|
US20090298894A1
(en)
*
|
2008-04-21 |
2009-12-03 |
Asahi Kasei Pharma Corporation |
Amino acid compounds
|
|
WO2010069949A1
(en)
*
|
2008-12-18 |
2010-06-24 |
Merck Serono S.A. |
Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
|
|
EP2202232A1
(en)
*
|
2008-12-26 |
2010-06-30 |
Laboratorios Almirall, S.A. |
1,2,4-oxadiazole derivatives and their therapeutic use
|
|
EP2210890A1
(en)
*
|
2009-01-19 |
2010-07-28 |
Almirall, S.A. |
Oxadiazole derivatives as S1P1 receptor agonists
|
|
EP2389377B1
(en)
|
2009-01-23 |
2014-07-16 |
Bristol-Myers Squibb Company |
Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
|
|
JP2012515787A
(ja)
|
2009-01-23 |
2012-07-12 |
ブリストル−マイヤーズ スクイブ カンパニー |
自己免疫疾患および炎症性疾患の処置におけるｓ１ｐアゴニストとしての置換オキサジアゾール誘導体
|
|
ES2405054T3
(es)
*
|
2009-01-23 |
2013-05-30 |
Bristol-Myers Squibb Company |
Derivados de pirazol-1,2,4-oxadiazol como agonistas de esfingosina-1-fosfato
|
|
US8399451B2
(en)
|
2009-08-07 |
2013-03-19 |
Bristol-Myers Squibb Company |
Heterocyclic compounds
|
|
JP5728487B2
(ja)
|
2009-10-29 |
2015-06-03 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
三環式ヘテロ環化合物
|
|
WO2011133734A1
(en)
|
2010-04-23 |
2011-10-27 |
Bristol-Myers Squibb Company |
4 - (5 - isoxazolyl or 5 - pyrrazolyl -1,2,4- oxadiazol - 3 - yl) -mandelic acid amides as sphingosin- 1 - phosphate 1 rreceptor agonists
|
|
JP5788507B2
(ja)
|
2010-07-20 |
2015-09-30 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
置換３−フェニル−１，２，４−オキサジアゾール化合物
|
|
EP2619190B1
(en)
|
2010-09-24 |
2015-08-12 |
Bristol-Myers Squibb Company |
Substituted oxadiazole compounds and their use as s1p1 agonists
|